跳至主要内容
临床试验/TCTR20221006005
TCTR20221006005招募中1 期

Effect of Pomegranate Extract (Punica Granatum L.) Supplementation in Arterial Pulmonary Hypertension in Children with Acyanotic Congenital Heart Disease

/A0 个研究点目标入组 36 人开始时间: 2022年10月6日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Months 至 10 Years(—)
性别
All

入选标准

  • Inclusion criteria are patient age 1 month until 10 years, diagnosed with acyanotic heart disease left to right shunt, given standard lung hypertension treatment and the parent had signed informed consent.

排除标准

  • Subjects were excluded if they had prior heart surgery, were planned to have surgery within 3 months, had chronic parenchymal lung disease, had chromosomal or other disease preventing normal development, had infection or renal impairment.

研究者

发起方
/A

相似试验